Article
Antifungal therapeutic potential of <i>Candida albicans</i> Fun30: screening and validation of novel inhibitors against <i>Candida albicans</i>
2025-07-10
Abstract excerpt
<h4>ABSTRACT</h4> WHO has listed Candida albicans as a fungal pathogen of priority. With the increasing incidence of C. albicans infection and limited treatment strategies, the identification of new drug targets and inhibitor molecules is of global concern. ATP-dependent chromatin remodelling proteins play a crucial role in regulating gene expression. Fun30 from C. albicans ( Ca Fun30) mediates DNA end-resect...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 29ce77d6-df3e-59a3-bcf7-b0b55ed5e07b
- DOI
- 10.1101/2025.07.07.663444
